Characteristics of patients surgically treated for primary hyperparathyroidism with and without
urolithiasis
INTRODUCTION
• Urolithiasis is a common disease in the general population.
• Lifetime risk is approximately 3–5% in women and 10–15% in males, with an increased
incidence during the past two to three decades
1,2INTRODUCTION
• The etiology of urolithiasis is multifactorial, but hypercalcemia and hypercalciuria are known to be the primary risk factors for stones
3• Patients with primary hyperparathyroidism(PHPT) tend to have elevation of serum calcium level
and urine calcium level
• Primary hyperparathyroidism is a known risk
• 2010, Wu et al: Prevalence assessed using imaging
techniques (Patients number:
3388)
=> Prevalence rate: 8%
PREVALENCE RATE
Adopt from “Nephrolithiasis and renal calcifications in Primary Hyperparathyroidism”
PREVALENCE RATE – TEMPORAL TREND
y = -0.7657x + 1560.5 R² = 0.0668
10 20 30 40 50 60 70 80
Percentage(%)
PURPOSE
• We hope to characterize the biochemical and
pathological features of patients with primary
hyperparathyroidism(PHPT) with and without
urolithiasis.
MATERIAL AND METHOD
• Patients:
- 49 patients with hyperparathyroidism who underwent parathyroidectmomy were collected from 2002-2010.
- 14 patients were ESRD. (Secondary hyperparathyroidism) - 35 patients were included(PHPT patient)
• Subgroups:
I: Patients with urolithiasis and without urolithiasis before
parathyroidectomy
• Demographics: Age, Body weight, Gender, Plasma Calcium, Plasma Phosphate, PTH, Plasma Creatinine and Pathology result.
• Operation: Routine bilateral cervical exploration performed. Pre-operative biopsy is not routine.
• Duration of follow-up: 1 year
• Stone recurrence: Patients who underwent
parathyroidectomy got urolithiasis within one year.
(KUB, Computed tomograpgy, Renal echo)
RESULT
RESULT
RESULT
• There are no significant differences between
parahyperthyroism patients with urolithiasis and without urolithiasis before operation in Age,
Gender, Body weight, Renal function,
Plasma calcium, Plasma phosphatate,
PTH and Pathological type.
RESULT
• The overall stone recurrence rate: 36 %
• Patients with stone recurrence after parathroidectomy have higher plasma calcium level than without stone recurrence (3.55 vs 2.94, p<0.05)
• No significant difference on pre-operative and post-operative group:
- Age
- Body weight - Plasma PTH, P
- Creatinine and estimated GFR - Pathological type
-Studies on potential predictors for stone formation in patients with PHPT -Studies on potential predictors for stone recurrence after parathyroidectomy
DISCUSSION AND LITERATURE REVIEW
AGE
• Wu et al. 2010: 3388 patients with PHPT, retrospective study (J Clin Endocrin Metab)
- Increase risk of nephrolithiasis: younger age - Hyperparathyroidism: younger age
predominant
• Odvina et al. 2007: 131 patients with PHPT, retrospective study (Uro Res)
- Increase risk of nephrolithiasis: younger age
Stone-former vs. Non-stone former(y/o): 49.8 vs. 53.8(p < 0.05)
AGE
• Mollerup et al. 1999: 297 patients, prospective (World J Surgery)
- Increased risk of nephrolithiasis: younger age (50 y/o vs. 61 y/o, p< 0.00001)
• Soreide et al. 1996: 1038 patients undergoing initial cervical exploration for primary hyperparathyroidism (PHPT),
retrospective (Surgery)
AGE
• No effect of age on risk of nephrolithiasis: - 2009 Berger et al: (J Urol.)
patient number: 60 patients with primary hyperparathyroidism - 2002 Frokjaer: patient number: 91 patients (World J Surgery) - NTUH: 35 patients with primary hyperparathyroidism
GENDER
• Cooperberg et al. 2007: 339 patients undergoing surgery for PHPT(Int J Urol) - Nephrolithiasis was more common among men than women
(40% vs 15%, P < 0.001)
• Odvina et al. 2007: 131 patients with PHPT, retrospective study (Uro Res) - Nephrolithiasis was more common among men than women
(38% vs 23.2%, P < 0.05)
• Seroide et al. 1996: 1038 patients undergoing initial cervical exploration for primary hyperparathyroidism (pHPT), retrospective (Surgery)
- Nephrolithiasis was more common among men than women
GENDER
• No effect of age on risk of nephrolithiasis:
- 2009 Berger: patient number: 60 patients with primary hyperparathyroidism (J Urol.)
- 2002 Frokjaer: patient number: 91 patients (World J Surgery) - 1999 Mollerup: 297 patients, prospective(World J Surgery) - NTUH: 35 patients with primary hyperparathyroidism
PLASMA CALCIUM LEVEL
• Lower in stone former group:
• Mollerup et al. 1999: 297 patients, prospective
- Stone former vs non-stone former (2.90 vs 3.04, p< 0.001)
PLASMA CALCIUM LEVEL
• No difference between stone former and non-stone former group:
- 2009 Berger: patient number: 60 patients with primary hyperparathyroidism (J Urol.)
- 2007 Odvina: 131 patients with PHPT, retrospective study (Uro Res)
- 2002 Frokjaer: patient number: 91 patients (World J Surgery) - 1996 Seroide: 1038 patients, retrospective(Surgery)
- 1990 Silverberg: 62 patients, retrospective(Am J Med) - NTUH: 35 patients with primary hyperparathyroidism
PLASMA PHOSPHATE LEVEL
• Lower in stone former group:
- Seroide et al. 1996: 1038 patients, retrospective(Surgery) => plasma phosphate was lower in stone former group
Stone former vs. Non-stone former: 2.7 vs. 2.8 (p < 0.05)
- Odvina et al. 2007: 131 patients with PHPT, retrospective study (Uro Res) => plasma phosphate was lower in stone former group
Stone former vs. Non-stone former: 2.55 vs. 2.74 (p < 0.05)
PLASMA PHOSPHATE LEVEL
• No difference between stone former and non-stone former group:
- 2009 Berger: patient number: 60 patients with primary hyperparathyroidism (J Urol.)
- 2002 Frokjaer: patient number: 91 patients (World J Surgery) - 1999 Mollerup: 297 patients, prospective (World J Surgery) - 1990 Silverberg: 62 patients, retrospective(Am J Med)
- NTUH: 35 patients with primary hyperparathyroidism
PLASMA PTH LEVEL
• No difference between stone former and non-stone former group:
- 2009 Berger: patient number: 60 patients with primary hyperparathyroidism (J Urol.)
- 2007 Odvina: 131 patients with PHPT, retrospective study (Uro Res)
- 2002 Frokjaer: patient number: 91 patients (World J Surgery) - 1999 Mollerup: 297 patients, prospective (World J Surgery) - 1996 Seroide: 1038 patients, retrospective (Surgery)
- 1990 Silverberg: 62 patients, retrospective (Am J Med)
SUMMARY: POTENTIAL PREDICTORS
Potential predictors Studies reporting increased risk Studies reporting no effects Age (Increased potential in
younger age)
(1) Wu et al. 2010 (2) Odvina et al. 2007 (3) Mollerup et al. 1999 (4) Soreide et al. 1996
(1) Berger et al. 2009 (2) Frokjaer et al. 2002 (3) NTUH
Gender(Male predominant) (1) Cooperberg et al. 2007 (2) Odvina et al. 2007 (3) Seroide et al. 1996
(1) Berger et al. 2009 (2) Frokjaer et al. 2002 (3) Mollerup et al. 1999 (4) NTUH
Plasma calcium level
(Lower in stone former group)
(1) Mollerup et al. 1999 (1) Berger et al. 2009 (2) Odvina et al. 2007 (3) Frokjaer et al. 2002 (4) Seroide et al. 1996 (5) Silverberg et al 1990 (6) NTUH
Potential predictors Studies reporting increased risk Studies reporting no effects Plasma phosphate(Lower in
stone former group)
(1) Seroide et al. 1996 (2) Odvina et al. 2007
(1) Berger et al. 2009 (2) Frokjaer et al. 2002 (3) Mollerup et al. 1999 (4) Silverberg et al. 1990 (5) NTUH
Plasma PTH level None (1) Berger et al. 2009
(2) Odvina et al. 2007 (3) Frokjaer et al. 2002 (4) Mollerup et al. 1999 (5) Seroide et al. 1996
SUMMARY: POTENTIAL PREDICTORS
The potential predictor of stone recurrence after parathyroidectomy
- 1999 Word Journal of Surgery: Charlotte L. Mollerup et al.
Renal stone and primary hyperparathyroidism:
Natural history of renal disease after successful parathyroidectomy.
• 107 patients:
Urolithiasis and parathyroidectomy
• Prospective follow up
• 5 years follow up
• Overall stone
recurrence rate: 29.9%
1999 MOLLERUP ET AL
• Patients with stone recurrence after
parathroidectomy have higher plasma calcium level than without
stone recurrence(3.55 vs 2.94, p<0.05)
NTUH
PATIENT STATUS POST PTX WITH STONE RECURRENCE
• Clinical studies have indicated that surgical cure does not completely eradicate hypercalciuria and hypophosphatemia, suggesting that these patients have some additional mineral disorder ( 2009 Park.et al (BJU Int. 103: 670-678)
• Associations between BMI and risk of renal stones after PTX: It has been suggested that the increased incidence of
nephrolithiasis in the general population during the last two to three decades. This maybe due to an increased excretion of urinary oxalate, uric acid, sodium, and phosphate in obese
LIMITATIONS
• Problem 1: Small population(n=35)
• Problem 2: Retrospective study
- Variable follow-up interval after parathyroidectomy: 12 months ~ 10+ years - Some missing data: KUB image, Lab data
• Problem 3: More important stone predictors are not available - 24hr Urine calcium level
- Urine calcium concentration - Plasma Vitamin D3
- Weight of parathyroid gland
CONCLUSION
• There are no significant differences between PHT patients with urolithiasis and without urolithiasis in age, gender, body weight, renal function, plasma calcium, plasma phosphatate, PTH and pathological type.
• The overall stone recurrence rate: 36 %
• Patients with stone recurrence after parathroidectomy have
higher plasma calcium level than without stone recurrence(3.55 vs 2.94, p<0.05)
• In clinical practice, post-parathyroidectomy patients who receive calcium supplement should closely monitor plasma calcium level because of the association of stone recurrence
THANKS FOR YOUR ATTENTION
REFERENCES
Park S, Pearle MS 2007 Pathophysiology and management of calcium stones. Urol Clin North Am 34:323–334
Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC 2003 Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–
1823
Pak CY 1991 Etiology and treatment of urolithiasis. Am J Kidney Dis 18:624–637
Wu B, Haigh PI, Hwang R, Ituarte PH, Liu IL, Hahn TJ, YehMW 2010 Underutilization of parathyroidectomy in elderly patients with primary hyperparathyroidism. J Clin Endocrinol Metab 95:4324–4330
Odvina CV, Sakhaee K, Heller HJ, Peterson RD, Poindexter JR, Padalino PK, PakCY2007 Biochemical characterization of primary hyperparathyroidism with and without kidney stones.
Urol Res 35:123–128
REFERENCES
Berger AD, Wu W, Eisner BH, Cooperberg MR, Duh QY, Stoller ML 2009 Patients with primary hyperparathyroidism—why do some form stones? J Urol 181:2141–2145
Rao DS, Phillips ER, Divine GW, Talpos GB 2004 Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89:5415–5422
Mollerup CL, Vestergaard P, Frøkjaer VG, Mosekilde L, Christiansen P, Blichert-Toft M 2002 Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ 325:807–810
So¨ reide JA, van Heerden JA, Grant CS, Lo CY, Ilstrup DM 1996 Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones.
Surgery 120:1033–1037;discussion 1037–1038
Frøkjaer VG, Mollerup CL 2002 Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone disease before and after parathyroidectomy. World J
REFERENCES
Cooperberg MR, Duh QY, Stackhouse GB, Stoller ML 2007 Oral calcium supplementation ssociated with decreased likelihood of nephrolithiasis prior to surgery for hyperparathyroidism.
Int J Urol 14:1113–1115
Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D, Clemens TL,
Bilezikian JP 1990 Nephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 89:327–334
Rejnmark L, Vestergaard P, Mosekilde L. Nephrolithiasis and renal calcifications in primary hyperparathyroidism. J Clin Endocrinol Metab 2011;96:2377-85.